Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-05 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-06-05 Paull Robert Bradley Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-06-05 Grunberg Gregory Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-06-05 KOVEN ANDREW I Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-06-05 Shah Rajeev M. Director Grant or award · Stock Option (right to buy) +21,000 21,000
2019-05-30 Rosen Howard B Director Purchase +5,000 $5.42 $27K 8,240
2019-01-02 Iwicki Mark T Chief Executive Officer Grant or award · Stock Option (right to buy) +460,000 460,000
2019-01-02 Brazzell Romulus K Chief Medical Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2019-01-02 Bazemore Todd Chief Operating Officer Grant or award · Stock Option (right to buy) +175,000 175,000
2019-01-02 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2019-01-02 Trachtenberg Eric Grant or award · Stock Option (right to buy) +165,000 165,000
2019-01-02 Reumuth Mary Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2018-10-05 Grunberg Gregory Director Purchase +606,060 $8.25 $5.0M 2,877,006
2018-10-03 Shah Rajeev M. Director Purchase +2,424,242 $8.25 $20.0M 4,537,478
2018-10-03 RA CAPITAL MANAGEMENT, LLC Director Purchase +2,424,242 $8.25 $20.0M 4,537,478
2018-06-12 Shah Rajeev M. Director Grant or award · Stock Option (right to buy) +12,960 12,960
2018-06-11 Paull Robert Bradley Director Other acquisition +477 1,074
2018-05-18 Paull Robert Bradley Director Other acquisition +597 597

Page 19 of 19 · 378 trades